New Agents in IBS 

1:40 pm – 2:05 pm

 
Dr. Jihong Chen, MD, PhD

Associate Professor
Division of Gastroenterology
Department of Medicine
Farncombe Family Digestive Health Research Institute
McMaster University. Canada

Areas of interest

Neurogenic and myogenic control of gastrointestinal motility.
Non-invasive diagnosis and treatment of neurogastrointestinal dysmotility.

Clinical

Treatment of refractory gastrointestinal dysmotility, including constipation and fecal incontinence. 
Early diagnosis and effective management of chronic intestinal pseudo-obstruction and gastroparesis.
Autonomic nervous system control of GI motility.

Consulting

  1. Patients with refractory gastrointestinal motility disorders.
  2. Gastrointestinal motility technical and theoretical consultation.
  3. Interpretation of complicated gastrointestinal motility tests.
  4. Breath hydrogen test interpretation.

Research

  1. Low-level laser therapy for constipation and fecal incontinence.
  2. Biomarkers of GI dysmotility in High-resolution colonic and anorectal manometry 
  3. Neurogenic and myogenic control of gastrointestinal motility
  4. Autonomic function assessment and monitoring
  5. Non-invasive neuromodulation for refractory GI disorders.
  6. Breath hydrogen testing: pathophysiology of intestinal bacterial overgrowth

Session Learning Objectives:
  • Pathophysiology of IBS symptoms
  • Common pharmacological agents in IBS
  • Other therapies of IBS